Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
Stock Information for Anixa Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.